Considering the prominent role of VDAC-mediated Ca2+ signaling, it is only consistent that altered Ca2+ handling via VDAC is also associated with pathophysiology of many diseases, including cancer, cardiovascular diseases, and neurodegenerative diseases. This evidence concerns the gene VDAC1 and cancer.